COL4A3 and diabetic kidney disease: To study the effect of SGLT2i in an experimental model of non-diabetic kidney disease, we developed immortalized podocytes and tubular cell lines established from SV40+; Col4a3+/+ (immorto-WT) and SV40+; Col4a3-/- (immorto-AS) mice.